
Obitocip 5 Tablet
Marketer
Cipla Ltd
Salt Composition
Obeticholic acid (5mg)
Overview Obitocip 5 Tablet
HepaticGuard 5mg tablets are indicated for monotherapy or combination regimens in primary biliary cholangitis management. They enhance hepatic function by suppressing bile acid synthesis and accelerating their hepatic clearance. This diminishes intrahepatic bile acid concentrations, mitigating their cytotoxic effects. HepaticGuard 5mg can be administered with or without food, consistently at evenly spaced intervals, as directed by your physician. Maintaining a regular dosing schedule aids adherence. Complete the prescribed course; premature cessation is discouraged. Commonly reported adverse effects include pruritus, lassitude, exanthema, pharyngodynia, vertigo, obstipation, arthralgia, eczematous dermatitis, and thyroid dysfunction. Report any persistent or worsening side effects to your doctor. Prior to commencing treatment, disclose any pre-existing medical conditions and all concomitant medications to your doctor, as interactions may occur. Pregnant or lactating individuals should seek medical counsel before initiating therapy.
Primary Ingredients of Obitocip 5 Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Obitocip 5 Tablet
Managing primary biliary cholangitis
Major Benefits of Obitocip 5 Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for Obitocip 5 Tablet. Ingest the tablet whole; avoid chewing, crushing, or breaking it. While Obitocip 5 Tablet can be administered with or without food, consistent timing is recommended.
Common Side effects of Obitocip 5 Tablet:
- Throat pain
- Itching
- Fatigue
- Abdominal discomfort
- Rash
- Joint pain
- Oropharyngeal pain
- Dizziness
- Constipation
- Peripheral edema
- Palpitations
- Fever
- Thyroid disorders
- Eczema
How to use Obitocip 5 Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Obitocip 5 Tablets can be administered with or without food, however, consistent daily timing is recommended.
How Obitocip 5 Tablet works:
Obitocip 5 Tablet activates the Farnesoid X receptor (FXR), modulating bile acid production, lipid processing, and glucose homeostasis. By suppressing bile acid synthesis and enhancing their excretion, Obitocip 5 Tablet diminishes hepatic bile acid stores, mitigating their harmful effects. This mechanism contributes to improved liver health.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Obitocip 5 Tablet lacks established safety data. Physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
Data on Obitocip 5 Tablet use in pregnancy are lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on Obitocip 5 Tablet use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingCONSULT YOUR DOCTOR
Obitocip 5 Tablet's impact on driving ability is undetermined. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Obitocip 5 Tablet is likely safe for individuals with kidney impairment. Existing evidence indicates dose modification may be unnecessary, but physician consultation is recommended.
LiverCAUTION
Patients with significant hepatic impairment should use Obitocip 5 Tablet cautiously, potentially requiring dose modification. Physician consultation is advised.
What if you forget to take Obitocip 5 Tablet :
Omit any missed Obitocip 5 Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Obitocip 5 Tablet
| Label | Value |
|---|---|
| Chemical Type | Bile acid alcohols and their derivatives |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal System |
